{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:56Z","timestamp":1792783736494,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Sinovac (Dalian) Vaccine Technology Co Ltd"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cmi.2018.12.033","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T02:24:13Z","timestamp":1546568653000},"page":"1026-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"25","author":[{"given":"B.","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.12.033_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.12.033_bib2","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2018.12.033_bib3","series-title":"China statistical yearbook","year":"2017"},{"key":"10.1016\/j.cmi.2018.12.033_bib4","first-page":"265","article-title":"Varicella and herpes zoster vaccines. WHO position paper, June 2014","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.cmi.2018.12.033_bib5","series-title":"The immunological basis for immunization series. Module 10: Varicella-zoster virus","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.cmi.2018.12.033_bib6","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1086\/522134","article-title":"Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement\u2014Maine, 2006","volume":"197","author":"Parker","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.033_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.033_bib8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.12.033_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/341089","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.033_bib10","first-page":"389","article-title":"Outbreak of varicella among vaccinated children\u2014Michigan, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2018.12.033_bib11","series-title":"The guidance principle of grade standard for adverse reactions that occur in clinical trial of prevention vaccines. Register no. 493","author":"Chinese State Food and Drug Administration (SFDA)","year":"2005"},{"key":"10.1016\/j.cmi.2018.12.033_bib12","first-page":"193","article-title":"Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine","volume":"15","author":"Ma","year":"2009","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"key":"10.1016\/j.cmi.2018.12.033_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000160947.89942.30","article-title":"Effectiveness of the Oka\/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel","volume":"24","author":"Sheffer","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.033_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The effectiveness of varicella vaccine in China","volume":"29","author":"Fu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.033_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2018.12.033_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002281-200101000-00006","article-title":"Henoch-Sch\u00f6nlein purpura","volume":"13","author":"Saulsbury","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cmi.2018.12.033_bib17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.12.033_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00006454-200204000-00014","article-title":"Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection","volume":"21","author":"Li","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.12.033_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine","volume":"20","author":"Watson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.033_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/172.1.217","article-title":"Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization","volume":"172","author":"Watson","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.12.033_bib21","series-title":"The epidemiology of varicella under a two-dose vaccination strategy: results of a mathematical transmission model with a novel strategy of sensitivity analysis","author":"Valeika","year":"2008"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18308450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18308450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:21:56Z","timestamp":1761117716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18308450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1198743X18308450"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}